+36.1%
MRNA vs VSAT
+207.8%
-171.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VSAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.2% | +5.2% | +5.3% |
| 7D | -1.1% | -1.3% | +0.3% | -0.9% |
| 30D | +126.1% | -14.8% | +140.9% | +133.3% |
| 3M | +190.0% | +2.2% | +187.8% | +185.4% |
| 6M | +157.2% | +60.2% | +97.0% | +130.4% |
| YTD | +388.2% | +115.6% | +272.6% | +312.2% |
| 1Y | +467.0% | +132.9% | +334.2% | +369.4% |
| 3Y | +36.1% | +216.1% | -180.0% | +0.3% |
| All | +36.1% | +207.8% | -171.8% | +0.3% |
Cumulative growth
Daily Returns
Daily percentage return beside VSAT.
Daily Out/Under-Performance
Portfolio return minus VSAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VSAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VSAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling